CN Patent

CN118873536A — 新方法

Assigned to Intra Cellular Therapies Inc · Expires 2024-11-01 · 2y expired

What this patent protects

本公开涉及包含游离形式或药学上可接受的盐形式的卢美哌隆、任选地与一种或多种另外的治疗剂组合的药物胶囊，其制备方法以及用于治疗或预防疾病的方法。

USPTO Abstract

本公开涉及包含游离形式或药学上可接受的盐形式的卢美哌隆、任选地与一种或多种另外的治疗剂组合的药物胶囊，其制备方法以及用于治疗或预防疾病的方法。

Drugs covered by this patent

lumateperone-tosylate (LUMATEPERONE TOSYLATE)

Patent Metadata

Patent number: CN118873536A
Jurisdiction: CN
Classification: —
Expires: 2024-11-01
Drug substance claim: No
Drug product claim: No
Assignee: Intra Cellular Therapies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.